ibrutinib 280 MG Oral Tablet [Imbruvica]

RxCUI: 2000023
RxNorm name: ibrutinib 280 MG Oral Tablet [Imbruvica]
Display name: ibrutinib 280 MG Oral Tablet [Imbruvica]
Full name: ibrutinib 280 MG Oral Tablet [Imbruvica]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Imbruvica	IBRUTINIB	Pharmacyclics LLC	0dfd0279-ff17-4ea9-89be-9803c71bab44	2025-10-21	Warnings, Adverse reactions	Exact identifier rxcui: 2000023

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
0dfd0279-ff17-4ea9-89be-9803c71bab44	Imbruvica 280 MG Oral Tablet [PSN] · ibrutinib 280 MG Oral Tablet [Imbruvica] [SBD] · Imbruvica 280 MG Oral Tablet [SY]	3	65	These highlights do not include all the information needed to use IMBRUVICA safely and effectively. See full prescribing information for IMBRUVICA. IMBRUVICA ® (ibrutinib) capsules, for oral use IMBRUVICA ® (ibrutinib) tablets, for oral use IMBRUVICA ® (ibrutinib) oral suspension Initial U.S. Approval: 2013	20251021